Morning Movers 6/12: SVNT, CRXX, APPY, RMBS, VICL Higher; HOKU, ARST, EZPW, OCLS, CPST Lower

June 12, 2009 9:01 AM EDT

Savient Pharmaceuticals (Nasdaq: SVNT) 44.5% HIGHER; a recent note from Wedbush Morgan said they expect an FDA Advisory Committee to recommend approval of KRYSTEXXA in refractory gout on June 16. The firm set a $15 price target.

CombinatoRx, Incorporated (NASDAQ: CRXX) 34.6% HIGHER; announced the presentation of full data on Synavive (CRx-102) Phase 2 knee osteoarthritis trial (COMET-1) at EULAR 2009, the Annual European Congress of Rheumatology in Copenhagen on June 12, 2009. Click here for the full report.

Hoku Scientific, Inc. (Nasdaq: HOKU) 31.7% LOWER; reports Q4 loss of $0.03, ex-items, 2 cents better than the analyst estimate of ($0.05). Revenue for the quarter was $112K, versus the consensus of $300K. Doesn't expect to issue FY10 sales guidance.

AspenBio Pharma (Nasdaq: APPY) 23.5% HIGHER; shares have jumped about 9% over the last 4 trading sessions, and with the stock moving above $2 between last night's close and the open today, technicians are likely buying the stock on a possible breakout. Is likely also moving higher as investors are playing to the swine flu trade.

ArcSight, Inc. (Nasdaq: ARST) 12.8% LOWER; reports Q4 EPS of $0.18, ex-items, 8 cents better than the analyst estimate of $0.13. Revenue for the quarter was $39.3 million, versus the consensus of $36.82 million. Sees Q1 sales of $31-$34 million, versus the consensus of $34.29 million. Sees Q1 adj-EPS of $0.03-$0.08, versus the Street estimate of $0.09.

Rambus Inc. (NASDAQ: RMBS) 12.5% HIGHER; today announced that it has reached a tentative settlement with the European Commission to resolve the pending case against the Company. Click here for the full report.

Vical (Nasdaq: VICL) 12% HIGHER; with the WHO's announcement yesterday that the swine flu alert level has been raised to a 6, related stocks are jumping today. The stock was also started at Thomas Weisel with an Overweight rating.

EZCORP (Nasdaq: EZPW) 11.2% LOWER; lowers its Q3 EPS guidance from about $0.34 to $0.29-$0.31, versus the consensus of $0.34 and its Q4 EPS outlook from $0.46-$0.48 to $0.41-$0.43, which compares to the Street estimate of $0.46. For FY09, EZCORP now sees EPS in the range of $1.40-$1.44, down from $1.50-$1.52 previously, and versus the consensus of $1.51. Click here for the full report.

Sonic Solutions (Nasdaq: SNIC) 10.8% HIGHER; upgraded to Outperform at William Blair.

Oculus Innovative Sciences, Inc. (NASDAQ: OCLS) 9.6% LOWER; reports Q4 loss of $0.13, compared to a loss of $0.34 in the same quarter last year. Revenue for the quarter was $1.5 million, versus $926,000 in Q408.

Saks (NYSE: SKS) 8.8% HIGHER; Deutsche Bank upgrades Saks from Hold to Buy and a Street High $7 price target. Click here for more color on the upgrade.

Trinity Biotech (Nasdaq: TRIB) 8.7% HIGHER; see Vical.

Capstone Turbine (Nasdaq: CPST) 7.8% LOWER; correcting today following yesterday's 80% surge.

Sinovac Biotech (AMEX: SVA) 7.6% HIGHER; see Vical.

Human Genome Sciences (Nasdaq: HGSI) 6.3% LOWER; Lazard downgrades from Hold to Sell.

Get This Report Daily Here: http://www.streetinsider.com/entities/StreetInsider.com+Morning+Movers.

Related Categories

Special Reports

Stocks Mentioned

Related Entities

• Deutsche Bank
• William Blair
• Lazard
• Wedbush Morgan
• Thomas Weisel Partners Group
• StreetInsider.com Morning Movers

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?